AzTrials
AzTrials

Inguinal HerniaNCT06997536

Comparison of Postoperative Analgesic Efficacy of Ultrasound-Guided Ilioinguinal-Iliohypogastric Block, Transversus Abdominis Plane Block, and Quadratus Lumborum Block in Inguinal Hernia Surgery

A study testing Ilioinguinal/iliohypogastric Nerve Block, Transversus abdominis plane (TAP) block and Quadratus Lumborum Block (QLB) in people with Inguinal Hernia and Transversus Abdominis Plane (TAP) Block, run by Namik Kemal University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Inguinal hernia is a common condition, particularly among male patients, and represents one of the most frequent indications for lower abdominal surgeries. Postoperative acute pain and, more importantly, the progression of acute pain into chronic pain, remain significant challenges in the postoperative period. Read more about this study

Who is it for?
Ages 18 to 75 years
What is being tested?
Ilioinguinal/iliohypogastric Nerve Block, Transversus abdominis plane (TAP) block and Quadratus Lumborum Block (QLB)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteTurkey (Türkiye)
Study dates
28 Jun 2022to 1 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients classified as ASA I and II
  • Patients aged 18 to 75 years
  • Patients undergoing unilateral inguinal hernia surgery under spinal anesthesia

Who cannot join

  • Patients with preoperative neurological sequelae
  • Patients with a BMI >30
  • Patients who refused to participate in the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Namik Kemal University

    Tekirdağ, 59020

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Postoperative Analgesic Efficacy of Ultrasound-Guided Ilioinguinal-Iliohypogastric Block, Transversus Abdominis Plane Block, and Quadratus Lumborum Block in Inguinal Hernia Surgery: A Prospective, Randomized Controlled Trial

Inguinal hernia is a common condition, particularly among male patients, and represents one of the most frequent indications for lower abdominal surgeries. Postoperative acute pain and, more importantly, the progression of acute pain into chronic pain, remain significant challenges in the postoperative period. Effective postoperative pain management is therefore crucial in inguinal hernia repair.

In addition to systemic analgesia, various regional anesthesia techniques are employed in this setting. In recent years, peripheral nerve blocks such as the ilioinguinal-iliohypogastric (IL/IH) block, transversus abdominis plane (TAP) block, and quadratus lumborum block (QLB) have gained popularity for postoperative analgesia. These techniques offer several advantages, including reduced opioid consumption and decreased need for additional analgesics, while also minimizing hemodynamic instability and facilitating early mobilization.

Read more

The IL/IH block is performed by injecting a local anesthetic into the fascial plane between the transversus abdominis and internal oblique muscles, targeting the ilioinguinal and iliohypogastric nerves, which are branches of the L1 spinal nerve. The TAP block, first described by Rafi in 2001, involves injecting local anesthetic into the fascial plane between the internal oblique and transversus abdominis muscles within the Petit triangle, where the T6-T11 spinal nerve branches responsible for abdominal wall innervation are located. The quadratus lumborum block (QLB) was initially described by Blanco. The first version, known as QLB1, involves posterior injection of local anesthetic lateral to the quadratus lumborum muscle. In 2013, Jens Børglum introduced the transmuscular variant (QLB3), where the local anesthetic is administered between the quadratus lumborum and psoas muscles.

In this study, we aimed to compare postoperative outcomes in patients undergoing inguinal hernia repair under spinal anesthesia, with and without additional peripheral nerve blocks (IL/IH block, TAP block, and QLB). Specifically, we evaluated pain levels using the Visual Analog Scale (VAS) at the 30th minute, 2nd, 6th, 12th, and 24th hours postoperatively. We also assessed opioid-related side effects such as nausea and vomiting associated with patient-controlled analgesia (PCA) using tramadol, the total bolus and infusion doses of tramadol administered, and the amount of additional analgesia in the form of paracetamol. These outcomes were compared among the different block groups and with a control group that received only spinal anesthesia without any additional block.

Being tested
Ilioinguinal/iliohypogastric Nerve Block, Transversus abdominis plane (TAP) block, Quadratus Lumborum Block (QLB)
Keywords
Inguinal hernia, Ilioinguinal-iliohypogastric block, Transversus abdominis plane block, Quadratus lumborum block
Medical subject headings
Hernia, Inguinal, Bites and Stings

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ilioinguinal/iliohypogastric Nerve BlockProcedure or surgery

    The aim of this study is to compare the analgesic efficacy of IL/IH block, TAP block, and QLB applied in inguinal hernia cases operated under spinal anesthesia, with each other and with a control group that did not receive any additional block to spinal anesthesia.

  • Transversus abdominis plane (TAP) blockProcedure or surgery

    The aim of this study is to compare the analgesic efficacy of IL/IH block, TAP block, and QLB applied in inguinal hernia cases operated under spinal anesthesia, with each other and with a control group that did not receive any additional block to spinal anesthesia.

  • Quadratus Lumborum Block (QLB)Procedure or surgery

    The aim of this study is to compare the analgesic efficacy of IL/IH block, TAP block, and QLB applied in inguinal hernia cases operated under spinal anesthesia, with each other and with a control group that did not receive any additional block to spinal anesthesia.

Study groups in NCT06997536
Study groupRoleWhat they receive
Ilioinguinal/Iliohypogastric BlockExperimentalAfter spinal anesthesia was applied, a preoperative ilioinguinal/iliohypogastric block was administered to the side to be operated on.
Receives: Procedure: Ilioinguinal/iliohypogastric Nerve Block
Transversus abdominis plane (TAP) blockExperimentalAfter spinal anesthesia was applied, a preoperative transversus abdominis plane (TAP) block was administered to the side to be operated on.
Receives: Procedure: Transversus abdominis plane (TAP) block
Quadratus Lumborum BlockExperimentalAfter spinal anesthesia was applied, a preoperative quadratus lumborum block (QLB) was administered to the side to be operated on.
Receives: Procedure: Quadratus Lumborum Block (QLB)
ControlNo interventionNo block was applied after spinal anesthesia.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Pain Score

    Postoperative pain will be assessed using a Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (the worst imaginable pain). Pain scores will be recorded at predefined time points during rest and movement.

    Measured: Postoperative 30th minute, 2nd, 6th, 12th and 24th hours

Secondary outcomes (1)
  1. Total Opioid Consumption at 24 Hours.

    For patient-controlled analgesia, tramadol 300 mg was prepared in 100 cc of isotonic saline with a concentration of 3 mg/cc. The infusion rate was set at 3 mL/hour, with a 5 mL bolus dose, a lock-out time of 4 hours, and the device was set to be used for 24 hours. In patients with a VAS score of 4 or higher despite opioid demand from the patient-controlled analgesia device, an additional 1 gram of IV paracetamol was planned to be administered as an adjunct analgesic. Total infusion and bolus doses of tramadol over 24 hours were recorded.

    Measured: At the end of the 24th hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2025
  2. Study start28 Jun 2022
  3. Primary completion28 Jun 2023
  4. Study completion1 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06997536
Sponsor's protocol ID
NamikKU-AGultekin-Meltem2025
Status last verified
May 2025
First submitted
21 May 2025
Last updated
30 May 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Savas Ozdemir M, Gultekin A, Sahin A, Arar C. Analgesic efficacy of ilioinguinal/iliohypogastric, transversus abdominis plane, and quadratus lumborum blocks in inguinal hernia surgery: A prospective randomized controlled trial. J Int Med Res. 2026 Jul;54(7):3000605261463857. doi: 10.1177/03000605261463857. Epub 2026 Jul 1.

    PubMed 42383898

Questions about this trial

What is this clinical trial studying?

A study testing Ilioinguinal/iliohypogastric Nerve Block, Transversus abdominis plane (TAP) block and Quadratus Lumborum Block (QLB) in people with Inguinal Hernia and Transversus Abdominis Plane (TAP) Block, run by Namik Kemal University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Pain Score (time frame: Postoperative 30th minute, 2nd, 6th, 12th and 24th hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06997536, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in